3D Systems Cleared Its Death Trap — the Profit Math Behind the 88% Rally Still Isn't There

3D Systems (NYSE: DDD) traded around $1.70 a year ago — a stock that had become, functionally, a bankruptcy wager. Its 2026 convertible notes, a wall of debt it had no cash to repay, were set to mature at a time when the company was still burning money. Today the stock sits near $3.30, up roughly 88% year to date, and the bulls have a clean story: management sold off the weak software businesses, ripped the 2026 debt out of the capital structure, and organic growth has returned. It is a real turn.

The key to the story, though, is separating the two things that rally has actually bought. One of them — survival — is proven and, critically, already priced. The other — a durable return to profitability — is a bet the forward math has not yet supported.

Start with the survival case, because it is genuinely strong. 3D Systems ran into 2025 with its 0% convertible notes due 2026 and no obvious way to pay them. It solved that problem by shrinking: through 2025 it divested its software businesses (Geomagic, 3DXpert, Oqton), and in December 2025 it exchanged roughly $30.8 million of the 2026 notes for about 16.6 million shares of stock, an earlier refinancing retireing the rest. What remains is almost nothing due soon — $3.9 million in principal maturing in the fourth quarter of 2026, against $92 million that does not roll over until 2030. Cash on hand was $129 million at the end of June. The debt wall that defined the risk is gone, and that deserves the re-rating.

The cracks are in the second half of the thesis — the word "corner" applied to profit, not just to survival. Look past the headline growth number. Revenue was flat year over year in Q2 ($94.6 million) and grew only 1.4% excluding the 2025 divestitures. That is the pattern: the company keeps reporting "organic growth" against a base it deliberately shrank, so the denominator does a lot of the work. Within it, the split is uneven — Healthcare grew 6.8% in Q2, while Industrial Solutions fell 6.7% and was still down 3.7% even after stripping out the sold units.

The profitability math is where the narrative and the numbers most clearly part. Adjusted EBITDA turned positive for the first half of 2026, at $1.3 million — the first encouraging signal in years. But it evaporated quarter to quarter, from a $2.1 million gain in Q1 to a $0.8 million loss in Q2, and management's own Q3 guidance calls for adjusted EBITDA of negative $3 million to negative $1 million. On a GAAP basis the company still lost $12.9 million in Q2 alone. Gross margin is sliding — down to 36.4% from 38.1% a year earlier — as the mix shifts toward new-printer sales at thinner prices. None of that is the signature of a business that has broken through to profit.

The most telling crack is cash. Over the trailing twelve months, 3D Systems burned $42 million in operating cash flow and $52 million in free cash flow. In Q2 alone it had to issue 18.9 million new shares to raise $53.2 million — selling roughly 11% of itself, at the current ~166 million share count, just to fund a quarter of losses. The survival fix left the balance sheet breathing, but it did not remove the need to dilute shareholders every time losses run past the cash balance. At $551 million in market value — roughly 1.4x trailing sales and about twice book value — the price already assumes the profitable-growth sequel arrives, not that the company is still selling stock to stay afloat.

The honest read is not that the turn is fake. The near-death risk was real, it was structural, and it has been cleared out; that leg of the rally was earned. The risk is that investors are now paying recovery multiples for a company whose own guidance says adjusted EBITDA goes back to a loss next quarter and whose free cash flow is still deeply negative — a company that must keep printing shares to fund the gap. The corner that was turned was the one in front of the debt wall. The corner in front of real, unleveraged, non-dilutive profit — that one is still a projection, and at this price the market is treating a projection as a fact.